IRIS
MAZZONE, MASSIMILIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.691
NA - Nord America 1.267
SA - Sud America 461
EU - Europa 208
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.663
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.210
SG - Singapore 1.098
BR - Brasile 405
CN - Cina 296
VN - Vietnam 90
HK - Hong Kong 72
IT - Italia 38
GB - Regno Unito 34
CA - Canada 33
DE - Germania 27
BD - Bangladesh 23
ES - Italia 21
IN - India 19
AR - Argentina 14
EC - Ecuador 14
JP - Giappone 14
PL - Polonia 14
RU - Federazione Russa 14
TR - Turchia 14
IQ - Iraq 13
ZA - Sudafrica 13
MX - Messico 11
UA - Ucraina 11
UZ - Uzbekistan 11
AT - Austria 9
PY - Paraguay 9
FR - Francia 7
NL - Olanda 6
PK - Pakistan 6
SE - Svezia 6
AE - Emirati Arabi Uniti 5
CZ - Repubblica Ceca 5
CO - Colombia 4
EG - Egitto 4
ID - Indonesia 4
KE - Kenya 4
LT - Lituania 4
PE - Perù 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
VE - Venezuela 4
CL - Cile 3
HN - Honduras 3
IE - Irlanda 3
JO - Giordania 3
SA - Arabia Saudita 3
AZ - Azerbaigian 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
FI - Finlandia 2
GA - Gabon 2
IL - Israele 2
LB - Libano 2
MA - Marocco 2
NG - Nigeria 2
PH - Filippine 2
PS - Palestinian Territory 2
BB - Barbados 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 3.663
Salva come PNG Salva come JPEG
Città #
Singapore 352
The Dalles 311
Shanghai 167
Dallas 161
Ashburn 126
Beijing 110
Hong Kong 71
Los Angeles 42
Ho Chi Minh City 33
São Paulo 32
Boardman 30
New York 30
Seattle 30
Santa Clara 23
Hanoi 22
Chandler 18
Rio de Janeiro 16
Montreal 15
Warsaw 14
Wilmington 14
Chicago 12
Belo Horizonte 11
Milan 11
Tokyo 11
Assago 10
Tashkent 10
Brooklyn 9
Council Bluffs 9
Curitiba 9
Denver 9
Murcia 9
Atlanta 8
Boston 8
Brasília 8
Johannesburg 8
Porto Alegre 8
Abbiategrasso 7
London 7
Munich 7
San Mateo 7
São José dos Campos 7
Ankara 6
Buffalo 6
Guayaquil 6
Stockholm 6
Vienna 6
Basra 5
Joinville 5
Manchester 5
Amsterdam 4
Arapiraca 4
Belém 4
Chennai 4
Columbus 4
Dhaka 4
Goiânia 4
Hải Dương 4
Jacobina 4
Lima 4
Montevideo 4
Orem 4
Reston 4
San Francisco 4
Secaucus 4
Woodbridge 4
Amman 3
Asunción 3
Brno 3
Calgary 3
Caçador 3
Chapecó 3
Charlotte 3
Da Nang 3
Dublin 3
Erbil 3
Florianópolis 3
Fortaleza 3
Ilhéus 3
Istanbul 3
Lauterbourg 3
Moscow 3
Nairobi 3
Osasco 3
Phủ Lý 3
Poplar 3
Quito 3
Tunis 3
Uberlândia 3
Volta Redonda 3
Águas Lindas de Goiás 3
Ann Arbor 2
Athens 2
Baghdad 2
Baku 2
Benin City 2
Biên Hòa 2
Cairo 2
Camaçari 2
Campinas 2
Campo Verde 2
Totale 2.006
Salva come PNG Salva come JPEG
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 130
Monocyte biomarkers for cancer detection 95
PHD2 inhibition for blood vessel normalization, and uses thereof 81
Nicotinamide phosphoribosyltransferase acts as a metabolic gate for mobilization of myeloid-derived suppressor cells 70
"Active" cancer immunotherapy by anti-Met antibody gene transfer 52
Modulating transendothelial migration and recruitment of granulocytes by modulating c-Met pathway 46
The PP2A B55a subunit as novel PHD2 interacting protein and implications for cancer 40
Induction/monitoring of arteriogenesis using SDF1 and PDGFB or inhibition of PHD2 39
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels 39
Functional MMP-10 is required for efficient tissue repair after experimental hind limb ischemia 37
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming 36
Building in resistance to endothelial cell death 36
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity 35
Targeting the bicarbonate transporter SLC4A4 overcomes immunosuppression and immunotherapy resistance in pancreatic cancer 34
B55α/PP2A limits endothelial cell apoptosis during vascular remodeling: A complementary approach to disrupt pathological vessels? 34
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells 34
Reprogramming of Amino Acid Transporters to Support Aspartate and Glutamate Dependency Sustains Endocrine Resistance in Breast Cancer 34
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates 33
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 33
Tumor-associated macrophages: a short compendium 33
Macrophage-derived glutamine boosts satellite cells and muscle regeneration 33
Blood Vessel Proximity Shapes Cancer Cell Metabolism 32
Caspase-8 modulates physiological and pathological angiogenesis during retina development 32
Brain Endothelial Cells Control Fertility through Ovarian-Steroid-Dependent Release of Semaphorin 3A 32
BNIP3 promotes HIF-1α-driven melanoma growth by curbing intracellular iron homeostasis 32
An uncleavable form of pro-scatter factor suppresses tumor growth and dissemination in mice 32
An HGF-MSP chimera disassociates the trophic properties of scatter factors from their pro-invasive activity 32
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization 31
Genetic targeting of the kinase activity of the Met receptor in cancer cells 30
Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation 30
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not? 30
Betulinic Acid Hydroxamate is Neuroprotective and Induces Protein Phosphatase 2A-Dependent HIF-1α Stabilization and Post-transcriptional Dephosphorylation of Prolyl Hydrolase 2 30
PHD1 regulates p53-mediated colorectal cancer chemoresistance 29
Quiescent Endothelial Cells Upregulate Fatty Acid β-Oxidation for Vasculoprotection via Redox Homeostasis 29
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 29
Branching morphogenesis and antiangiogenesis candidates: Tip cells lead the way 28
SLC25A26 overexpression impairs cell function via mtDNA hypermethylation and rewiring of methyl metabolism 28
A collaborative synthetase 28
Overcoming Resistance to Antiangiogenic Therapies 27
FLT1 and its ligands VEGFB and PlGF: Drug targets for anti-angiogenic therapy? 27
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer 27
Dynamic stroma reorganization drives blood vessel dysmorphia during glioma growth 26
Protein Phosphatase 2A Mediates YAP Activation in Endothelial Cells Upon VEGF Stimulation and Matrix Stiffness 26
The Met pathway: master switch and drug target in cancer progression 26
Tumour growth inhibition and anti-metastatic activity of a mutated furin-resistant Semaphorin 3E isoform 26
The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells 26
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling 26
Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses 25
Tanycytic VEGF-A boosts blood-hypothalamus barrier plasticity and access of metabolic signals to the arcuate nucleus in response to fasting 25
Preclinical and clinical evaluation of MET functions in cancer cells and in the tumor stroma 25
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene 25
Neutrophils enhance early Trypanosoma brucei infection onset 25
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium 25
Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation 25
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis 24
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis 24
Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited 24
Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia 24
Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury 24
Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models 24
Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy 24
Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival 24
Regulation of Angiogenesis by Oxygen and Metabolism 24
Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis 23
Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia 23
Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity 23
The impact of hypoxia on tumor-associated macrophages 23
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation 23
Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity 23
Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties 23
Tumor vessel co-option probed by single-cell analysis 23
Growing tumor vessels: More than one way to skin a cat - Implications for angiogenesis targeted cancer therapies 23
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 23
Tumor stroma: A complexity dictated by the hypoxic tumor microenvironment 23
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor 23
Immunity, hypoxia, and metabolism–the ménage à trois of cancer: Implications for immunotherapy 23
Leptin brain entry via a tanycytic LepR–EGFR shuttle controls lipid metabolism and pancreas function 22
MET is required for the recruitment of anti-tumoural neutrophils 22
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in Cancer 22
PHD2 Targeting Overcomes Breast Cancer Cell Death upon Glucose Starvation in a PP2A/B55α-Mediated Manner 22
Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism 22
Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization 22
IL1b promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D 22
Isolation and separation of murine tumor-associated macrophages (TAMs) subpopulations from orthotopic 4T1 breast tumors 22
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice 22
Regulation of Blood and Lymphatic Vessels by Immune Cells in Tumors and Metastasis 22
The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity 22
Metabolism and TAM functions—it takes two to tango 22
Metabolic traits ruling the specificity of the immune response in different cancer types 22
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 21
MiR-511-3p Modulates Genetic Programs of Tumor-Associated Macrophages 21
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis 21
Role and therapeutic potential of VEGF in the nervous system 21
HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF 21
Glufosinate constrains synchronous and metachronous metastasis by promoting anti-tumor macrophages 21
The c-MET receptor tyrosine kinase contributes to neutrophil-driven pathology in cutaneous leishmaniasis 21
Copy number load predicts outcome of metastatic colorectal cancer patients receiving bevacizumab combination therapy 21
FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis 21
Prolyl Hydroxylases in fight or flight 21
N-acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages 21
Totale 2.962
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.819
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 6 3 2 6 2 0 4
2021/202218 0 0 0 3 0 0 0 2 0 2 6 5
2022/202345 5 2 3 7 2 4 0 5 11 3 3 0
2023/2024532 0 3 3 3 2 4 2 1 147 27 146 194
2024/20251.461 45 5 4 14 11 119 84 92 302 396 184 205
2025/20261.737 642 357 246 296 141 55 0 0 0 0 0 0
Totale 3.819